Clinical trials: Travelers' Diarrhea
- Condition Travelers' Diarrhea
- Funder type Industry (pharma, biotech, devices)
- Age group Children (under 18)
Traveler's Diarrhea
Evaluate Safety and Efficacy of Rifamycin SV MMX in the Treatment of Traveler's Diarrhea in Children Age 6 to 11 Years
This will be a double-blind comparative study, performed in pediatric subjects (Age 6-11) traveling to developing regions with a known high incidence of traveler's diarrhea.
- Trial name
- NCT04026984
- Testing
- Rifamycin SV-MMX
- Volunteers
- 142 people
- Sponsor
- RedHill Biopharma Limited
Traveler's Diarrhea
Study to Evaluate Safety and Efficacy of Rifamycin SV MMX in Treating Traveler's Diarrhea in Children Age 12 to 17 Years
This will be a double blind comparative study, performed in pediatric subjects (Age 12-17) traveling to developing regions with a known high incidence of traveler's diarrhea.
- Trial name
- NCT04027894
- Testing
- Rifamycin SV MMX
- Volunteers
- 142 people
- Sponsor
- RedHill Biopharma Limited